16/04/2019 07:46:03

Olainfarm appoints new contact for investor relations – Jānis Dubrovskis

JSC Olainfarm hereby informs that from now on, Investor Relations Advisor Jānis Dubrovskis will be the core contact person for shareholders and investors.

The contact details of Jānis Dubrovskis are the following:  contact e-mail: janis.dubrovskis@olainfarm.com; contact phone: +371 29178878.

Jānis Dubrovskis has broad experience in capital markets and corporate finance fields. Since 2003 Mr. Jānis Dubrovskis held various positions at banks in Latvia, including Member of the Board at AS BlueOrange Bank from 2017 to 2019.

JSC Olainfarm will continue to introduce investors to the consolidated and non-consolidated performance of the company by publishing information quarterly. The company will continue previous webinar practices, dates will be reported separately. At any other time, investors are welcomed to have a dialog personally by contacting J.Dubrovskis.

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of the company's operations is to produce reliable and effective top -quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 60 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Information prepared by:

Dana Hasana, Head of PR

JSC Olainfarm

dana.hasana@olainfarm.com

+371 26355895

logo.jpg

Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
18 Apr
I:SP500
  Hejsa.   Lige lidt læsestof til påsken.   Langsigtet konjunktur:   Overraskende stigning i de le..
49
18 Apr
 
Jeg har modtaget flg. fra Delfin : "Nå, så er jeg blokeret på EI. Hvorfor ved jeg ikke. Jeg har ikke..
42
17 Apr
VELO
  Den eneste TA-ekspert var for mig alpehue, og nogle ganske få andre. Langt de fleste, som udtaler ..
28
20 Apr
NOVO-B
En lille påskehilsen fra Alpe, med mulighed for Novo.   https://invst.ly/al3nf  
26
21 Apr
NOVO-B
Det var bare mig, der havde spurgt Alpe om en streg på Novo, hvorefter jeg modtog dette, og gerne må..
22
17 Apr
 
EI hvorfor har I slettet mit indlæg 414414 og hele debatten om hvad en moderater bør blande sig i ? ..
21
21 Apr
NOVO-B
Er du dum, VI VIL HAVE ALPE TILBAGE
14
19 Apr
 
EI har spillet fallit, jeg har været med her i 15 år, og folk der kun er her for at ødelægge debatte..
12
17 Apr
TEVA
Den er også svær lige nu fordi mange korte og lange signaler krydser ind over hinanden lige nu. Men ..
11
20 Apr
ZEAL
Nedenfor er en artikle fra Ritzau fra 2018 som gennemgår situationen med Zealand Pharmas tyske samar..
10

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
With $3M Dividend in 2019, Nonprofit Insurer's Dividends Paid to Members Top $44.1M
2
Extendicare Announces Nomination of Two New Directors and Agreement with Sandpiper Group
3
Hua Medicine Initiates First Combination Study of Dorzagliatin with SGLT-2 in the United States
4
PDF Solutions® Announces First Fiscal Quarter Financial Results Release Date
5
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Nokia Corporation (NOK) and Encourages NOK Investors to Contact the Firm

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
23 April 2019 23:36:11
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190410.2 - EUROWEB7 - 2019-04-24 00:36:11 - 2019-04-23 23:36:11 - 1000 - Website: OKAY